Sort by
Refine Your Search
-
. Through hands-on experience, fellows will work with various cross-functional teams to learn the role of Medical Affairs, develop skills in the analysis, interpretation, and communication of clinical data
-
, bioCSL. The Medical Affairs fellow will assist across all pertinent areas of medical affairs within CSL Seqirus. The fellow will have rotations in medical information, medical communications & publications
-
practical clinical knowledge to enable efficient and effective drug development. Clinical Scientists contribute throughout the development cycle from Phase 1 to IND submission. They are data-driven
-
and advisory boards · Contribute to the development and planning of scientific platforms, communications and training materials, data dissemination, and other global medical resources
-
scientifically balanced information on Abbott's products to healthcare providers. Support medical affairs by providing product information expertise on a wide range of initiatives including medical review
-
-functional study teams for the design, execution, and monitoring of clinical trials, as well as assisting with data interpretation and communication. This role will also serve as a point of contact for
-
. Throughout the fellowship, the fellow will engage in projects to learn and understand different disease states, product data, and the roles and functions within Medical Affairs. The fellow will develop
-
to product approval and customer use, particularly related to the training and educational aspects of the product. Job Duties · Provide unbiased scientifically balanced information on Abbott’s products
-
orthosteric) and ion channels (a4b2 nAChR, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation
-
independently and take initiative on a variety of projects at both the industry site and Northeastern Additional Information Applicants should submit the following application materials by the priority deadline